1. Home
  2. CRVS vs LEG Comparison

CRVS vs LEG Comparison

Compare CRVS & LEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.31

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Leggett & Platt Incorporated

LEG

Leggett & Platt Incorporated

N/A

Current Price

$9.37

Market Cap

1.5B

ML Signal

N/A

Company Overview

Basic Information
Metric
CRVS
LEG
Founded
2014
1883
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
CRVS
LEG
Price
$14.31
$9.37
Analyst Decision
Strong Buy
Hold
Analyst Count
6
4
Target Price
$30.17
$10.50
AVG Volume (30 Days)
771.2K
1.8M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
1.85%
EPS Growth
48.04
145.31
EPS
N/A
0.47
Revenue
N/A
$5,203,900,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.73
P/E Ratio
N/A
$20.02
Revenue Growth
N/A
1.37
52 Week Low
$5.29
$8.34
52 Week High
$26.95
$13.00

Technical Indicators

Market Signals
Indicator
CRVS
LEG
Relative Strength Index (RSI) 49.46 38.66
Support Level $14.24 $8.57
Resistance Level $16.66 $11.45
Average True Range (ATR) 0.72 0.27
MACD -0.00 -0.01
Stochastic Oscillator 50.00 5.00

Price Performance

Historical Comparison
CRVS
LEG

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About LEG Leggett & Platt Incorporated

Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the maximum of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.

Share on Social Networks: